COMPARATIVE LUNG BIOAVAILABILITY OF HFA-SERETIDE VIA SPACER DEVICES IN HEALTHY VOLUNTEERS - Systemic bioavailability of Seretide via spacer devices
- Conditions
- Bronchial Asthma
- Registration Number
- EUCTR2006-001104-36-GB
- Lead Sponsor
- niversity of Dundee (Research & Innovation Services)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
1.Healthy Volunteers
2.Male or female 18-65
3.Informed Consent
4.Ability to comply with the requirements of the protocol
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
1.No respiratory disease
2.Smokers
3.Recent respiratory tract infection (2 months).
4.Any other clinically significant medical condition such as unstable angina,
acute myocardial infarction in the preceding 3 months, recent TIA/
CVA,that may endanger the health or safety of the participant, or
jeopardise the protocol.
5.Any significant abnormal laboratory result as deemed by the investigators
6.Pregnancy, planned pregnancy or lactation
7.Known or suspected contra-indication to any of the IMP’s
8.Concomitant use of medicines (prescribed, over the counter or herbal) that
may interfere with the trial
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method